Galectin-3 stabilizes heterogeneous nuclear ribonucleoprotein Q to maintain proliferation of human colon cancer cells

Cellular and Molecular Life Sciences

Volumn 66, Issue 2, 2009, Pages 350-364

  Yoo, B C ^a   Hong, S H ^a,b   Ku, J L ^b   Kim, Y H ^a   Shin, Y K ^a,b   Jang, S G ^a,b   Kim, I J ^c   Jeong, S Y ^b   Park, J G ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

5 fluorouracil; Colon cancer; Galectin 3; HnRNP Q; Proliferation; Protein stability

Indexed keywords

ANTIBODY; FLUOROURACIL; GALECTIN 3; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANTIMETABOLITES; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUOROURACIL; GALECTIN 3; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN ISOFORMS; PROTEIN KINASES; PROTEOME; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION;

EID: 59149092073     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-009-8562-3     Document Type: Article

References (34)

1. Sobrero, A. F., Aschele, C. and Bertino, J. R. (1997) Fluorouracil in colorectal cancer-a tale to of two drugs implications for biochemical modulation. J. Clin. Oncol. 15, 368-381.
2. Yoo, B. C., Jeon, E., Hong, S. H., Shin, Y. K., Chang, H. J. and Park, J. G. (2004) Metabotropic glutamate receptor 4-mediated 5-fluorouracil resistance in a human colon cancer cell line. Clin. Cancer Res. 10, 4176-4184.
3. Chang, H. J., Yoo, B. C., Lim, S. B., Jeong, S. Y., Kim, W. H. and Park J. G. (2005) Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin. Cancer Res. 11, 3288-3295.
4. Shin, Y. K., Yoo, B. C., Chang, H. J., Jeon, E., Hong, S. H., Jung, M. S., Lim, S. J. and Park, J. G. (2005) Down-regulation of mitochondrial F1F0 ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res. 65, 3162-3170.
5. Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizie, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K., Lefflera, H., Liuh, F. T., Leffler, H., Liu, F. T., Lotan, R., Mercurio, A. M., Monsigny, M., Pillai, S., Poirer, F., Raz, A., Rigby, P. W. J., Rini, J. M. and Wang, J. L. (1994) Galectins: a family of animal β- galactoside-binding lectins (Letter). Cell 76, 597-598.
6. Yang, R. Y. and Liu, F. T. (2003) Galectins in cell growth and apoptosis. Cell. Mol. Life. Sci. 60, 267-276.
7. Hughes, R. C. (2001) Galectins as modulators of cell adhesion. Biochimie 83, 667-676.
8. Perillo, N. L., Marcus, M. E. and Baum, L. G. (1998) Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76, 402-412.
9. Inohara, H. and Raz, A. (1995) Functional evidence that cell surface galectin-3 mediate homotypic cell adhesion. Cancer Res. 55, 3267-3271.
10. Inohara, H., Akahani, S. and Raz, A. (1998) Galectin-3 stimulates cell proliferation. Exp. Cell. Res. 245, 294-302.
11. Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J. and Raz, A. (2000) Galectin-3 induces endothelial cell morphogenesis and angiogenesis. Am. J. Pathol. 156, 899-909.
12. Fukumori, T., Takenaka, Y., Oka, N., Yoshii, T., Hogan, V., Inohara, H., Kanayama, H. O., Kim, H. R. and Raz, A. (2004) Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways. Cancer Res. 64, 3376-3379.
13. Fukumor,i T., Oka, N., Takenaka, Y., Nangia-Makker, P., Elsamman, E., Kasai, T., Shono, M., Kanayama, H. O., Ellerhorst, J., Lotan, R. and Raz, A. (2006) Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res. 66, 3114-3119.
14. Akahani, S., Nangia-Makker, P., Inohara, H., Kim, H. R. and Raz, A. (1997) Galectin-3: a novel anti-apoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57, 5272-5276.
15. Park, J. G., Oie, H. K., Sugarbaker, P. H., Henslee, J. G., Chen, T. R., Johnson, B. E. and Gazdar, A. (1987) Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 47, 6710-6718.
16. Oh, J. H., Ku, J. L., Yoon, K. A., Kwon, H. J., Kim, W. H., Park, H. S., Yeo, K. S., Song, S. Y., Chung, J. K. and Park, J. G. (1999) Establishment and characterization of 12 human colorectal-carcinoma cell lines. Int. J. Cancer 81, 902-910.
17. Kim, H. R., Lin, H. M., Biliran, H. and Raz, A. (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59, 4148-4154.
18. Lin, H. M., Moon, B. K., Yu, F. and Kim, H. R. (2000) Galectin-3 mediates genistein-induced G (2)/M arrest and inhibits apoptosis. Carcinogenesis 21, 1941-1945.
19. Yoshii, T., Fukumori, T., Honjo, Y., Inohara, H., Kim, H. R. and Raz, A. (2002) Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277, 6852-6857.
20. Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H. R., Bresalier, R. S. and Raz, A. (2004) Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol. Cell. Biol. 24, 4395-4406.
21. Kaaijk, P., Kaspers, G. J., Van Wering, E. R., Broekema, G. J., Loonen, A. H., Hählen, K., Schmiegelow, K., Janka-Schaub, G. E., Henze, G., Creutzig, U. and Veerman, A. J. (2003) Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Br. J. Cancer 88, 775-781.
22. Itamochi, H., Kigawa, J., Sugiyama, T., Kikuchi, Y., Suzuki, M. and Terakawa, N. (2002) Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet. Gynecol. 100, 281-287.
23. Maeda, N., Kawada, N., Seki, S., Arakawa, T., Ikeda, K., Iwao, H., Okuyama, H., Hirabayashi, J., Kasai, K. and Yoshizato, K. (2003) Stimulation of proliferation of rat hepatic stellate cells by galectin-1 and galectin-3 through different intracellular signaling pathways. J. Biol. Chem. 278, 18938-18944.
24. Oki, E., Baba, H., Tokunaga, E., Nakamura, T., Ueda, N., Futatsugi, M., Mashino, K., Yamamoto, M., Ikebe, M., Kakeji, Y. and Maehara, Y. (2005) Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer. Int. J. Cancer 117, 376-380.
25. Sasaki, S., Bao, Q. and Hughes, R. C. (1999) Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies. J. Pathol. 187, 481-489.
26. Islam. S., Hassan, F., Tumurkhuu, G., Ito, H., Koide, N., Mori, I., Yoshida, T. and Yokochi, T. (2007) 5-Fluorouracil prevents lipopolysaccharide- induced nitric oxide production in RAW 264.7 macrophage cells by inhibiting Akt-dependent nuclear factor-kappaB activation. Cancer Chemother. Pharmacol. 59, 227-233.
27. Bu, X., Jia, F., Wang, W., Guo, X., Wu, M. and Wei, L. (2007) Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells. BMC. Cancer 41, 208.
28. Dreyfuss, G., Kim, V. N. and Kataoka, N. (2002) Messenger-RNA-binding proteins and the messages they carry. Nat. Rev. Mol. Cell. Biol. 3, 195-205.
29. Krecic, A. M. and Swanson, M. S. (1999) hnRNP complexes: composition, structure, and function. Curr. Opin. Cell. Biol. 11, 363-371.
30. Shyu, A. B. and Wilkinson. M. F. (2000) The double lives of shuttling mRNA binding proteins. Cell 102, 135-138.
31. Pino, I., Pío, R., Toledo, G., Zabalegui, N., Vicent, S., Rey, N., Lozano, M. D., Torre, W., García-Foncillas, J. and Montuenga, L. M. (2003) Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer. 41, 131-143.
32. Zhou, J., Allred, D. C., Avis, I., Martínez, A., Vos, M. D., Smith. L., Treston, A. M. and Mulshine, J. L. (2001) Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res. Treat. 66, 217-224.
33. He, Y., Brown, M. A., Rothnagel, J. A., Saunders, N. A. and Smith, R. (2005) Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J. Cell. Sci. 118, 3173-3183.
34. Laing, J. G. and Wang, J. L. (1998) Identification of carbohydrate binding protein 35 in heterogeneous nuclear ribonucleoprotein complex. Biochemistry 27, 5329-5334.